Biotechnology

Targeting cancer at the molecular level through nuclear medicine, 3B Pharmaceuticals GmbH is a privately held pharmaceutical R&D company headquartered in Berlin, Germany. The…

A proprietary vector discovery platform called Therapeutic Vector Evolution sits at the centre of 4DMT 's approach to genetic medicine. Rather than relying on existing delivery…

Focused exclusively on the treatment of muscle wasting disorders , Actimed Therapeutics is advancing a pipeline of novel compounds targeting cancer-related cachexia and related…

A proprietary antibody engineering platform sits at the core of Adagene , a Nasdaq-listed, clinical-stage immunotherapy company working to redefine how antibodies are discovered…

Adaptimmune is built around a singular conviction: that engineered T-cells can be directed to fight cancer with precision and durability. The clinical-stage biopharmaceutical…

Founded in 2021 and headquartered in San Diego, California, Adcentrx Therapeutics is a clinical-stage biotechnology company focused on developing next-generation antibody-drug…

Anchored in the science of human plasma, ADMA Biologics operates as a fully vertically integrated commercial biopharmaceutical company applying patented immunotechnology to…

Founded in Edinburgh in 2017, AdoRx Therapeutics is a clinical-stage oncology drug discovery company built around a single well-validated biological insight: high concentrations…

Founded in 2018 by Professor Steve Jackson in partnership with Ahren Innovation Capital, Adrestia Therapeutics was a Cambridge-based biotech that pioneered a novel approach to…

At the forefront of a differentiated approach to cancer treatment, Akari Therapeutics is a Nasdaq-listed oncology biotechnology company (ticker: AKTX) developing a new class of…

Trusted by the cell and gene therapy sector since 2006, Akron Biotech supplies the ancillary materials that underpin advanced therapeutic manufacturing. Operating under the Akron…

Alacris Theranostics positions itself as a systems medicine company, delivering integrated next-generation sequencing (NGS) services and bioinformatics solutions designed to…

A proprietary platform for mining human antibody repertoires sits at the core of Alchemab Therapeutics , a clinical-stage biotechnology company working to identify novel drug…

Alcresta Therapeutics develops enzyme-based products targeting fat malabsorption in patients with rare diseases who rely on enteral feeding for nutrition. The company focuses on…

Mining what it describes as the deepest layers of plasma knowledge, Alkahest combines artificial intelligence, multiomics analysis and real-world data with deep plasma protein…

AMO Pharma is building a portfolio of new medicines targeting serious and debilitating diseases, with a particular focus on rare and orphan genetic disorders. The privately held…

Grounded in a proprietary boron chemistry platform , AN2 Therapeutics is a clinical-stage biopharmaceutical company advancing novel small-molecule therapeutics for rare, chronic,…

ASLAN Pharmaceuticals is a dual-listed (NASDAQ: ASLN; Taiwan Stock Exchange) clinical-stage biopharmaceutical company headquartered in Singapore, with operations in Taiwan and the…

AstraZeneca is one of the world's largest biopharmaceutical companies , with its global headquarters at the Cambridge Biomedical Campus in England. Founded in 1999 through the…

Founded in Aberdeen, Scotland, Elasmogen Ltd is a privately held biopharmaceutical company advancing a proprietary platform of next-generation biologics called soloMERs . These…

Emergex Vaccines is a UK-based clinical-stage biotechnology company developing a new class of synthetic peptide vaccines designed to stimulate cytotoxic T-lymphocyte (CTL)…

Pioneering second-generation complement therapeutics , Invizius is a Scottish biotech company dedicated to improving outcomes for patients with autoimmune and inflammatory…

Kuros Biosciences pioneers biologic bone graft technologies designed to advance bone healing through the combination of innovation and clinical evidence. The Swiss-headquartered…

Lifebit is a UK-headquartered technology company that has built its reputation on solving one of the most persistent problems in biomedical research: enabling scientists to…

Mereo BioPharma is a rare disease biopharmaceutical company built around a distinctive model: acquiring and developing clinical-stage assets that larger organisations have…

Founded in 2010 and headquartered in Cambridge, Massachusetts, Moderna is a clinical-stage biotechnology company listed on the Nasdaq (ticker: MRNA) that has built its entire…

Novavax, Inc. is a Gaithersburg, Maryland-based vaccine biotechnology company founded in 1987 and listed on NASDAQ (ticker: NVAX), best known for developing protein subunit…

Antigen-specific immunotherapy is the clinical focus of Barinthus Biotherapeutics plc (formerly Vaccitech), a clinical-stage biopharmaceutical company dedicated to guiding T cells…